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Background:Atopicalantimicrobialthatcandecreasethebacterialbioburdenofchronic
woundswithoutimpairingthewound’sabilitytohealisatherapeuticimperative.Astabi-
lized form of hypochlorous acid (NVC-101) has been demonstrated in vitro and in stan-
dard toxicity testing to possess properties that could fulfill these criteria. Materials and
Methods: Using a standard rodent model of a chronically infected granulating wound,
various preparations of NVC-101 and multiple treatment regimens were investigated to
evaluate the role of NVC-101 in decreasing tissue bacterial bioburden and overcoming
theinhibitionofinfectiononwoundhealing.Quantitativebacteriologyoftissuebiopsies
and wound healing trajectories were used to compare the various NVC-101 preparations
and regimens to saline-treated negative controls and silver sulfadiazine–treated positive
controls. Results: NVC-101 at 0.01% hypochlorous acid with a pH of 3.5 to 4.0 proved
to be an effective topical antimicrobial. It was most effective when used for a brief
period (15–30 minutes), and followed with another application. Possibly this was due
to its rapid neutralization in the wound bed environment. Although not as effective at
decreasingthetissuebacterialbioburdenassilversulfadiazine,NVC-101wasassociated
with improved wound closure. Conclusions: This stabilized form of hypochlorous acid
(NVC-101) could have potential application as an antimicrobial wound irrigation and
treatment solution if its effective pH range can be maintained in the clinical situation.
NVC-101 solution was equally effective at pH 3.5 or 4.0 and more efficient soon after
its application. As opposed to other antimicrobials investigated in this animal model,
NVC-101 controls the tissue bacterial bioburden without inhibiting the wound healing
process.
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Woundhealingistheendresultofaseriesofinterrelatedcellularprocessesinitiatedby
humoral factors such as cytokine growth factors.1 These cellular processes are inhibited by
a large tissue bacterial bioburden.2 The cytokines and growth factors are also degraded
by bacteria.3 The level of tissue bacterial bioburden has been shown in multiple studies
to be more than 105 or at least 1 × 106 bacteria per gram of tissue.4,5 Such high levels
of tissue bacteria can be present without clinical signs of infection, and when present can
deleteriously affect wound healing.6
Attemptsatcontrollingthetissuebacterialbioburdenhavebeendifficult.Systemically
administered antibiotics do not effectively decrease the level of bacteria in a chronic granu-
lating wound.7 Therefore, topical antimicrobials or temporary biologic dressings have been
themethodsofchoice.4,8 Topicaluseofantibioticsthatareusedeffectivelysystemicallyfor
purposes other than wound infection is discouraged because of an increased risk for devel-
oping allergies or the potential for bacteria to develop resistance to the drug.9 Antiseptics
and nonantibiotic antimicrobials such as povidone-iodine, silver sulfadiazine, or mafenide
acetate cream have been demonstrated to be cytotoxic to the cellular components of wound
healing.10−12
Stabilizedhypochlorousacid(NVC-101)preparedbytheadditionofsodiumhypochlo-
rite to a solution of sodium chloride in sterile water followed by addition of a solution of
hydrochloric acid and maintained at a pH between 3.5 and 5 has been demonstrated to
have excellent in vitro antibacterial properties. Its potential limitation is the requirement to
maintain its narrow pH range in the clinical wound environment.
The purpose of the studies reported here was to evaluate various concentrations of
stabilized hypochlorous acid (NVC-101) topically administered to an experimental chronic
infected granulating wound at different pHs and with different treatment regimens. The
effects evaluated were the ability of NVC-101 to control the tissue bacterial bioburden and
the ability of the agent to overcome the inhibition of wound healing caused by infection.
MATERIALS AND METHODS
Reagents
The various NVC-101 preparations ranging in concentrations from 0.01% to 0.02% and
from pH 3.5 to 4.5 were provided by NovaBay Pharmaceuticals, Emeryville, Calif. In brief,
thestabilizedHOClwaspreparedin150mMNaClbyacidifyingreagent-gradeNaOCltothe
pH of 3.5 to 4.5 with dilute HCl. The concentration of active chlorine species ([HOCl]T =
[HOCl] + [Cl2] + [Cl3] + [OCl−]) in 0.9% saline was determined by converting all the
activechlorinespeciestoOCl− with0.1MNaOHandmeasuringtheconcentrationofOCl−
spectrophotometrically at 292 nm using a molar absorbtivity of 362 M−1 cm−1.13
Microbiological methods
Escherichiacoli(ATCC25922)waspurchasedfromtheAmericanTypeCultureCollection,
and grown and propagated according to the ATCC recommendations. Bacteria for use in
the animal model were obtained from fresh 18-hour broth culture, and inoculum size was
confirmed by back-plating.
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Animal model of chronic granulating wound
Chronic granulating wounds were prepared as previously described.7,14−16 Male Sprague-
Dawley rats weighing 300 to 350 g were acclimated in the facility for a week before
use. Under intraperitoneal pentobarbital (Nembutal) anesthesia (35 mg/kg), the rat dorsum
was shaved and depilated. A full-thickness dorsal burn measuring 30 cm2 was created by
immersing in boiling water. Infected groups were seeded with 5 × 109 CFU of E. coli
(ATCC 25922) after the rats had been allowed to cool for 15 min.16
Animals were individually caged and given food and water ad libitum. Uninfected
animals were kept in a physically separate facility. All experiments were conducted in
accordance with the American Care and Use Committee at the Department of Veterans
Affairs Medical Center, Bay Pines, Fla.
Five days after burning, the eschar was excised from anesthetized animals, resulting in
a chronic granulating wound. Histological characterization of this wound with comparison
to a human granulating wound has previously been performed.7
Treatment groups
Two different experiments using multiple treatment regimens were performed. In exper-
iment 1, 45 rats were divided into 9 groups of 5 animals each. The groups were treated
as follows: group I served as uninfected controls and received no inoculation of bacteria.
Following escharectomy, these rats were treated with a saline (0.9% NaCl)-soaked gauze
dressing, which was changed every 24 hours. Group II was an infected control and was
inoculated, as were groups III to VIII. After escharectomy, the rats in group II were treated
with daily changes of saline-soaked gauze dressing. Group III animals had their escharec-
tomized infected wounds treated with gauze dressing saturated with 0.01% NVC-101, pH
3.5, changed every 24 hours. Groups IV and IVb were treated identically. Animals in these
2 groups had their escharectomized infected wounds treated with a dressing soaked with
0.01% NVC-101, pH 3.5, which remained in place for 30 minutes and then was replaced
with a dressing soaked in 0.9% NaCl for 23.5 hours. This regimen was repeated every
24 hours. Group V received similar treatment as group III except that the 0.01% NVC-101
had a pH of 4.0. The regimen for group VI was similar to groups III and V except that
the pH was adjusted to 4.5. Group VII was treated similarly to group III except that the
concentration of NVC-101 was increased 0.02%, with the pH at 3.5. Finally, group VIII
animals were treated with 1% silver sulfadiazine cream (Silvadene) without dressing and
changedevery24hours.ThemoistgauzedressingsingroupsItoVIIwerecoveredwithone
layer of petrolatum-impregnated gauze (Adaptic) and then covered with Coban dressing. A
summary of animal treatment groups is depicted in Table 1.
Followingevaluationoftheresultsofexperiment1,invitromodificationsoftechniques
were investigated. It was decided that wiping off the wound following an initial application
of stabilized hypochlorous acid and then replacing it may have added benefits (data not
presented).
Experiment 2 consisted of 8 groups of 5 animals each. Group I served as the infected
controlandescharectomizedinfectedwoundsweretreatedwith0.9%NaCl–soakeddressing
changed every 24 hours. Group II was treated with a gauze soaked in 0.01% NVC-101, pH
3.5, for 15 minutes, followed by gentle atraumatic wiping of the wound, and then treated by
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III Infected/NVC-101, 0.01%, pH 3.5, changed q24 h
IV Infected/NVC-101, 0.01%, pH 3.5, 30 min/23.5 h normal saline
IVb Infected/NVC-101, 0.01%, pH 3.5, 30 min/23.5 h normal saline
V Infected/NVC-101, 0.01%, pH 4.0, changed q24 h
VI Infected/NVC-101, 0.01%, pH 4.5, changed q24 h
VII Infected/NVC-101, 0.02%, pH 3.5, changed q24 h
VIII Infected/Silvadene changed q24 h
∗Five animals per group.
anotherapplicationof0.01%NVC-101,pH3.5,for23.75hours.Thisregimenwasrepeated
every 24 hours. Group III was treated the same as group II except that the pH of NVC-101
solution was adjusted to pH 4.0. The regimen for group IV was identical to group III using
thepH4.0solutionasthefirstapplication.However,afterthegentlewiping,0.9%NaClwas
substitutedfortheremaining23.75hoursinsteadofarepeatapplicationofNVC-101.Group
V had normal saline (0.9% NaCl) applied on the first dressing for 15 minutes, followed by
wiping, and then another saline-soaked dressing for 23.75 hours. This was repeated every
24 hours. Group VI was treated identical to group II and had a 15-minute application of
0.01%NVC-101,pH3.5,followedbywiping,butthenfollowedbyagauzedressingsoaked
with 0.01% NVC-101, pH 3.5, left in place for 47.75 hours. This was repeated every 48
hours. Group VII mimicked group VI except that the second dressing consisted of a saline-
soaked sponge for 47.75 hours. Finally, group VIII animals were treated after escharectomy
with a 0.9% NaCl–soaked dressing for 30 minutes, followed by 23.5 hours of a second
saline-soaked dressing. No gentle wiping was interspersed between dressings in group
VIII. A summary of the animal treatment groups in experiment 2 is depicted in Table 2.
Animal procedures
In experiment 1, rats were premedicated with buprinorphine (0.1 mg/kg) and anesthetized
with halothane inhalation on postescharectomy days 4, 8, 12, 16, and 20. Any dried
exudates that formed were atraumatically removed. Wounds were biopsied for quantitative
Table 2. Summary of treatment/group of rats in experiment 2
Group∗ Treatment
I Infected/normal saline
II Infected/NVC-101, 0.01%, pH 3.5, 15 min, wipe, then q23.75 h NVC-101, pH 3.5
III Infected/NVC-101, 0.01%, pH 4.0, 15 min, wipe, then q23.75 h NVC-101, pH 4.0
IV Infected/NVC-101, 0.01%, pH 4.0, 15 min, wipe, then q23.75 h normal saline
V Infected/normal saline, 15 min, wipe, then q23.75 h normal saline
VI Infected/NVC-101, 0.01%, pH 3.5, 15 min, wipe, then q47.75 h NVC-101, pH 3.5
VII Infected/NVC-101, 0.01%, pH 3.5, 15 min, wipe, then q47.75 h normal saline
VIII Infected/normal saline, 30 min, no wipe, then q23.75 h NVC-101, pH 3.5
∗Five animals per group.
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bacteriology on the day of escharectomy (day 0) and on each of the days of reanesthesia ac-
cordingtothemethodsdescribedbyHeggersandRobson.5 Thewoundsurfacewascleaned
with 70% isopropyl alcohol prior to biopsy to exclude surface contamination. Biopsies
were aseptically weighed, homogenized, serially diluted, and back-plated onto nonselec-
tive media. Bacterial counts were completed after 48 hours’ incubation and expressed as
colony-forming units (CFU) per gram of tissue.5
While the rats were anesthetized for the wound biopsies, outlines of the wounds were
traced onto acetate sheets, and area calculations were performed using computerized dig-
ital planimetry (Sigma Scan Jandel Scientific, Corte Madera, CA). Care was taken only
to record the perimeter of the wound that represented the advancing full-thickness margin
rather than the edge of any advancing epithelium. This avoided the small component of ad-
vancementprovidedbythesmooth,pink,translucent,hairlessneoepithelium.16 Allanimals
were weighed at the time of biopsy and wound measurement.
The animals were sacrificed by Nembutal overdose and bilateral thoracotomies when
thewoundhadcompletelyhealedordecreasedtolessthan10%ofitsoriginalarea.Haywood
et al demonstrated that measurement of very small wounds by manual tracing introduced
significant systematic error and found that wounds followed past this point remained static
for prolonged periods of time.17
Theanimalsinexperiment2hadthesameproceduresperformedasthoseinexperiment
1 except they were performed at different time points, that is, days 0, 2, 4, 7, 9, 11, and
14, with the final wound size recorded on day 16. The time points were chosen to capture
earlier time points and more frequent changes in the wound size and bacteriology.
Statistical analysis
Mean bacterial counts for each group of animals in both experiments were determined and
expressedasCFU/goftissue.Thesevalueswerecomparedforeachexperimentusingaone-
way analysis of variance. Post hoc analyses of differences between groups were carried out
usingTukey’stest(allpairs,multiple-comparisontest),withP <. 05consideredsignificant.
Sigma Stat statistical software (Jandel Scientific, Corte Madera, CA) was used for data
analysis.
Serial wound area measurements were plotted against time. For each animal’s data, a
Gompertz equation was fitted (typical r2 = 0.85).18 Using this approach, a best-fit curve
was generated for each group. Comparison between groups was performed using life table
analysesandtheWilcoxonranktest.ThesestatisticalanalyseswereperformedusingSAS19
and BMDP20 packages on a personal computer.
RESULTS
Quantitative bacteriology
Quantitative bacteriology of the chronic granulating wounds treated with various formu-
lations of stabilized HOCl (NVC-101) or Silvadene were determined. The mean bacterial
counts for each biopsy day in experiment 1 are depicted in Table 3. Plots of mean log10
versus time for the various treated groups in experiment 1 are depicted in Figure 1 with the
statistical comparisons.
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Table 3. Summary of mean bacterial counts for each treated group in experiment 1
Days of punch biopsy postescharectomy (mean CFU/g)
Group∗ Day 0 Day 4 Day 8 Day 12 Day 16 Day 20
I 8.4 × 102 2.48 × 103 1.49 × 104 1.63 × 104 3.71 × 104 8.04 × 103
II 2.92 × 107 8.96 × 106 4.88 × 105 1.39 × 105 1.68 × 105 2.12 × 104
III 3.12 × 107 1.39 × 105 3.6 × 104 3.24 × 104 5.28 × 104 5.16 × 103
IV 2.42 × 107 1.72 × 105 1.31 × 103 4.92 × 103 8.8 × 102 1.0 × 101
IVb 9.52 × 107 3.36 × 107 1.28 × 105 1.51 × 104 2.05 × 103 1.5 × 102
V 1.56 × 108 1.37 × 105 8.6 × 104 2.05 × 104 6.36 × 103 3.12 × 103
VI 2.45 × 107 1.44 × 105 1.25 × 105 6.14 × 104 3.56 × 104 1.38 × 104
VII 2.01 × 108 1.45 × 105 5.8 × 104 9.75 × 104 3.89 × 104 9.7 × 103
VIII 6.52 × 107 3.75 × 106 2.4 × 104 NG† NG NG
∗Five animals per group.
†NG indicates no growth.
It is clear that Silvadene was the best topical antimicrobial at decreasing the tissue
bacterial burden. 0.01% NVC-101, pH 3.5, applied for 30 minutes and then removed from
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Uninfected / normal saline Infected / normal saline
Infected / NVC-101, 0.01%,  pH 3.5, changed q24 h Infected / NVC-101, 0.01%,  pH 3.5, 30 min / 23.5, h normal saline
Infected / NVC-101, 0.01%,  pH 3.5, 30 min / 23.5 h normal saline Infected / NVC-101, 0.01 %,  pH 4.0, changed q24 h
Infected / NVC-101, 0.01%,  pH 4.5, changed q24 h Infected / NVC-101, 0.02%,  pH 3.5, changed q24 h
Infected / Silvadene changed q24 h
Figure 1. Depictionofthevariousgroupsinexperiment1demonstratingthesuperiorityof30min-
utes of NVC-101 application followed by another dressing for 23.5 hours over other regimens of
hypochlorous acid. 1% silver sulfadiazine cream (Silvadene) was the most effective of all agents
tested at decreasing the tissue bacterial bioburden.
mean log10 versus time for the various groups in experiment 2 are depicted in Figure
2 with statistical comparisons. Experiment 2 greatly expanded the knowledge of dosing
regimen for NVC-101. Experiment 2 looked more carefully at the earlier, more frequent
time points. Three regimens in experiment 2 were as good as or better than the best reg-
imen in experiment 1 at decreasing the tissue bacterial burden. Groups II, III, and IV
all had counts less than 103 CFU/g of tissue by day 14. In groups II and III, which
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Table 4. Summary of mean bacterial counts for each treated group in experiment 2
Days of punch biopsy postescharectomy (mean CFU/g)
Group∗ Day 0 Day 2 Day 4 Day 7 Day 9 Day 11 Day 14
I 5.0 × 108 5.0 × 108 1.27 × 108 1.4 × 107 1.85 × 106 2.32 × 105 1.41 × 105
II 5.0 × 108 1.59 × 106 8.74 × 105 1.03 × 105 8.8 × 103 3.48 × 103 5.0 × 102
III 5.0 × 108 3.24 × 106 2.51 × 106 3.12 × 104 2.54 × 103 3.48 × 103 6.4 × 102
IV 5.0 × 108 1.12 × 108 2.31 × 107 1.37 × 107 9.16 × 104 7.28 × 103 4.0 × 102
V 5.0 × 108 5.0 × 108 2.78 × 107 4.38 × 106 8.53 × 105 2.53 × 105 4.4 × 104
VI 5.0 × 108 2.01 × 107 2.60 × 107 7.74 × 106 2.24 × 105 3.68 × 104 1.60 × 103
VII 5.0 × 108 2.17 × 108 4.06 × 107 4.06 × 107 3.48 × 106 1.95 × 105 1.56 × 103
VIII 5.0 × 108 4.01 × 108 5.24 × 107 2.72 × 107 1.58 × 106 2.42 × 105 4.04 × 104
∗Five animals per group.
Figure 2. Depiction of the various groups in experiment 2 demonstrating
thesuperiorityatdecreasingbacterialcountsofNVC-101appliedfor15min-
utes, followed by gentle atraumatic wiping then 23.75 hours of a second
dressing of NVC-101. There was essentially no difference in the effects
with pH 3.5 and 4.0.
86ROBSON ET AL
had essentially the same treatment regimens, the bacterial counts decreased more rapidly
than in group IV . For these groups (II and III), the regimen consisted of NVC-101 being
placed on the wound for 15 minutes, atraumatically wiped off, and then reapplied for 23.75
hours. The only difference between the treatments for groups II and III was the pH of
NVC-101. No significant differences were seen between pH 3.5 and pH 4.0 (Table 4 and
Fig 2).
Body weights
There was an equivalent gain in body weight among all groups during the period of study,
with no significant variations among the groups in either experiment 1 or experiment 2
Wound area
Best-fit healing curves demonstrated that none of the treatment regimens resulted in the
area of the wound increasing in size (Figs 3 and 4).
Infected control animals (group II in experiment 1, group I in experiment 2) retarded
healing as compared to the noninfected controls (group I in experiment 1). Healing curves
for groups IV and IVb in experiment 1 demonstrated statistically significant increases in
reduction in the fraction of open wounds when compared to groups I, III, V , and VIII (P <
.05)andgroupsII,V ,andVII(P <.01)(Fig3).GroupsII,V ,andVIIdemonstratedaslower
trajectory than all other groups, also statistically significant (P < .05) (Fig 3).
In experiment 2, healing curves for groups II and III demonstrated statistically signif-
icant larger reductions in the fraction of open wounds when compared to groups IV , VI,
and VII (P < 0.05) and groups I, V , and VIII (P < .01) (Fig 4). Groups I, V , and VIII
demonstrated a slower healing trajectory than all other groups, which was also statistically
significant (P < .05).
DISCUSSION
Because of the deleterious effect of a high tissue bacterial burden on the process of wound
healing, an effectual antimicrobial agent becomes a therapeutic imperative. Such an agent
should be effective as a topical preparation, yet not to be cytotoxic to the cells involved in
the wound healing process.21 Stabilized hypochlorous acid, as tested in the 2 experiments
reported,mayprovetobesuchanagent.Itsinvitroantibacterialpropertiesandtissuesafety
profilesuggestitspotentialasawoundcareagent.13 However,itislikelyrapidlyneutralized
in the wound environment.
Inexperiment1,Silvadenewas,asexpected,themosteffectiveantibacterial.However,
Silvadene was not as effective at promoting wound closure as were two of the NVC-101
regimens (IV and IVb) (Fig 3). The healing that occurred with Silvadene was probably due
to elimination of the tissue bacterial load (Table 3). The reason the wounds did not totally
heal or exceed that with groups IV and IVb is because of the known cytotoxic properties of
Silvadene.11,12
From a review of the quantitative bacteriology data from both experiments, it is clear
that a brief application of NVC-101, followed by a second dressing change is better than a
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Figure 3. Wound healing trajectories from experiment 1, demonstrating
fasterhealingforgroupsIVandIVbtreatedwithashortapplicationofNVC-
101 followed by a second dressing of normal saline. These 2 groups had a
more favorable wound healing trajectory than did group VIII treated with 1%
silver sulfadiazine cream (Silvadene).
single application of NVC-101 left in place for 24 hours (group III, experiment 1) (Tables 3
and 4).21 When the second dressing is again NVC-101 (groups II and III from experiment
2), the rate of bacterial reduction is faster than when the initial application of NVC-101 is
followed by normal saline (groups IV and IVb in experiment 1, or group IV in experiment
2) (Table 3 and 4, and Figs 1 and 2). There was no apparent difference in the wound healing
trajectory whether the second dressing contained NVC-101 or saline (Figs 3 and 4).
It is clear that the effect of NVC-101 on bacteria occurs in a short period of time after
application. Possibly leaving NVC-101 in place for 24 hours stimulates greater plasma or
serum response to inflammatory stimuli and that plasma milieu allowed bacterial growth
overtime.ThisisnotunlikesuggestionsfromFleming’sclassicarticleof1919.21 Therefore,
it may be useful to use NVC-101 for a short duration of time. The initial bacterial kill by




II and III, which consisted of a brief application of NVC-101, followed by gentle wiping, and a
second application of NVC-101 over other regimens. The 2 groups with the fastest healing were
also the most effective at controlling the tissue bacterial bioburden.
since when only saline was used in 1 or 2 applications, the bacterial kill was less (group II,
experiment 1; groups V and VIII, experiment 2) (Tables 3 and 4, Figs 1 and 2).
The differences between pH 3.5 and 4.0 were not detectable. However, when the pH of
NVC-101 was raised to 4.5, the control of the tissue bacterial burden seemed slightly less
effective, with a slower wound healing trajectory. Therefore, it appears that a pH of 3.5 or
4.0 may be more useful. However, these differences may not be significant.
Theroleoftheatraumaticwipingbetweendressingapplicationsisnotentirelyclear.If
NVC-101killsbacteriaimmediatelyorsoonafterinitialcontact,thenthegentlewipingmay
remove the devitalized bacteria and any possible debris, allowing the second application of
NVC-101 to be in immediate contact with any remaining viable bacteria. This may explain
the faster decrease in tissue bacterial levels seen in groups II and III in experiment 2.
In conclusion, the pilot in vivo study results for the 2 experiments indicate that the
stabilized form of hypochlorous acid (NVC-101) is equally effective at pH 3.5 or 4.0 and
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more effective soon after its application. As opposed to other antimicrobials investigated in
this animal model, NVC-101 controls the tissue bacterial bioburden without inhibiting the
wound healing process.
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